FRCPath Haem Part 1 MCQ-Oncology 253

A 63yr-old pt with R/R myeloma has progressed after multiple prior therapies. Started on agent that targets CD3 and B-cell maturation antigen. Name?

• Talquetamab
• Cevostamab
• Elranatamab
• Blinatumomab

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now